Close Menu

The Washington Post reports that the National Institutes of Health has approved 13 additional human embryonic stem cell lines as eligible for federal funding this week. On the list is H9 — the most widely used hESC line, developed by researchers at the University of Wisconsin, Madison-affiliated WiCell Research Institute, which had previously been approved under the administration of former President Bush.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News reports the US National Institutes of Health is investing in studies of the long-term effects of COVID-19.

The National Health Service is to offer Novartis's Zolgensma for spinal muscular atrophy later this year, according to the Guardian.

Taiwan is to launch a pilot program offering genetic testing to cancer patients, the Taipei Times reports.

In PLOS this week: loci linked to protection against tuberculosis, identification of loci associated with increased risk of squamous cell carcinoma of the aerodigestive tract, and more.